Aurora – October 14, 2026 -- Adults with type 2 diabetes who do not take insulin spent about five more hours per day within their target blood sugar range when using continuous glucose monitors (CGMs) than patients receiving routine care, according to a randomized trial published in the New England Journal of Medicine.

Nearly twice as many CGM users reached an A1c below 7%, a common treatment goal. The A1c gap between the two groups was 0.9 percentage points, which the researchers say greatly exceeds the threshold generally considered clinically meaningful.